Treatment for Minor Stroke (Transient Ischemic Attack)
Patients with transient ischemic attack (TIA) require immediate medical attention and urgent initiation of dual antiplatelet therapy with aspirin plus clopidogrel for 21-90 days, followed by long-term single antiplatelet therapy to prevent recurrent stroke. 1
Risk Stratification and Initial Management
Very High Risk TIAs (symptoms within 48 hours)
- Patients with transient, fluctuating, or persistent unilateral weakness (face, arm, leg) or speech disturbance should be:
High Risk TIAs (symptoms between 48 hours and 2 weeks)
- Patients with transient, fluctuating, or persistent unilateral weakness or speech disturbance should be assessed within 24-48 hours 1
- Same imaging and diagnostic workup as very high-risk patients
Acute Treatment
Antiplatelet Therapy:
- First 21-90 days: Dual antiplatelet therapy with aspirin (81-325 mg daily) plus clopidogrel (75 mg daily) started within 24 hours of symptom onset 1
- After initial period: Single antiplatelet therapy with one of the following:
- Aspirin 81-325 mg daily
- Clopidogrel 75 mg daily
- Aspirin-dipyridamole extended-release combination 1
Blood Pressure Management:
Lipid Management:
Specific Management Based on Etiology
Large Artery Atherosclerosis
- For 50-99% intracranial stenosis: Aspirin 325 mg/day is recommended over warfarin 1
- For 70-99% ipsilateral extracranial carotid stenosis: Refer for carotid endarterectomy within 6 months of the event 1
- For 50-69% ipsilateral extracranial carotid stenosis: Consider endarterectomy for selected patients 1
- Angioplasty and stenting should NOT be performed as initial treatment for intracranial stenosis 1
Cardioembolic TIA
- For atrial fibrillation: Prescribe oral anticoagulation unless contraindicated 1
- Prefer direct oral anticoagulants (apixaban, dabigatran, edoxaban, rivaroxaban) over warfarin except for patients with mechanical heart valves or moderate-severe mitral stenosis 1
Follow-up Care
- Initial follow-up within 2-4 weeks after the event 3
- Subsequent follow-up every 3-6 months 3
- Monitor and manage all modifiable risk factors:
- Hypertension
- Diabetes (target HbA1c ≤7%)
- Dyslipidemia
- Smoking cessation
- Weight management
- Physical activity
Common Pitfalls to Avoid
Delayed Treatment: The risk of recurrent stroke is highest in the first 48 hours after TIA. Delaying treatment can lead to preventable strokes 4
Inadequate Risk Stratification: Not all TIAs carry the same risk. Use the ABCD² score to help determine urgency of evaluation 3
Failure to Recognize Symptoms: Up to 70% of patients do not correctly recognize TIA symptoms, leading to treatment delays. Patient education is crucial 5, 6
Substituting Antiplatelet Therapy for Acute Stroke Treatment: Antiplatelet therapy should not replace IV alteplase or mechanical thrombectomy in eligible patients 1
Underestimating Outpatient Management: For appropriate patients, outpatient management in specialized TIA clinics can be as effective as inpatient care and more cost-efficient 7
The EXPRESS study demonstrated that urgent assessment and immediate treatment of TIA reduced the 90-day risk of recurrent stroke by 80% compared to usual care (from 10.3% to 2.1%) 4. This highlights the critical importance of rapid evaluation and treatment initiation for all patients with TIA.